ITGA9 anticorps (C-Term)
Aperçu rapide pour ITGA9 anticorps (C-Term) (ABIN5517556)
Antigène
Voir toutes ITGA9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- ISLLVGILIF LLLAVLLWKM GFFRRRYKEI IEAEKNRKEN EDSWDWVQKN
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the C terminal region of human ITGA9
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- ITGA9 (Integrin alpha-9 (ITGA9))
-
Autre désignation
- ITGA9
-
Sujet
-
This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers.
Alias Symbols: RLC, ITGA4L, ALPHA-RLC
Protein Size: 1035 -
ID gène
- 3680
-
NCBI Accession
- NM_002207, NP_002198
-
UniProt
- Q13797
Antigène
-